Literature DB >> 6432299

Preliminary observations of a form of coherence therapy for osteoporosis.

C Anderson, R D Cape, R G Crilly, A B Hodsman, B M Wolfe.   

Abstract

Five patients suffering from osteoporosis were subjected to from three to eight cycles of a form of Coherence Therapy for Osteoporosis (1) used at this center. Assessment of the patients' trabecular bone remodeling activity as measured by histomorphometric analyses of trans-iliac crest bone biopsies showed a marked improvement.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432299     DOI: 10.1007/bf02405341

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

1.  The role of phosphate in the secretion of parathyroid hormone in man.

Authors:  E Reiss; J M Canterbury; M A Bercovitz; E L Kaplan
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

2.  A new semiautomatic method for quantitative static and dynamic bone histology.

Authors:  H H Malluche; D Sherman; W Meyer; S G Massry
Journal:  Calcif Tissue Int       Date:  1982-09       Impact factor: 4.333

3.  Coherence treatment of osteoporoses.

Authors:  H M Frost
Journal:  Orthop Clin North Am       Date:  1981-07       Impact factor: 2.472

4.  Stimulation of bone formation in vivo by phosphate supplementation.

Authors:  W H Harris; R P Heaney; L A Davis; E H Weinberg; R D Coutts; A L Schiller
Journal:  Calcif Tissue Res       Date:  1976-11-24

5.  Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.

Authors:  R S Goldsmith; J Jowsey; W J Dubé; B L Riggs; C D Arnaud; P J Kelly
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

6.  Effects of alternating phosphorus and calcium infusions on osteoporosis.

Authors:  M M Popovtzer; M Stjernholm; W E Huffer
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

  6 in total
  17 in total

Review 1.  Toward a cure for osteoporosis: reversal of excessive bone fragility.

Authors:  C H Turner
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

Review 2.  Transient-steady state phenomena in microdamage physiology: a proposed algorithm for lamellar bone.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1989-06       Impact factor: 4.333

3.  Some ABCs of skeletal pathophysiology. III: Bone balance and the delta B.BMU.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1989-09       Impact factor: 4.333

4.  Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)--Osteoporosis Study I, Hannover.

Authors:  G Delling; T Dreyer; M Vogel; M Hahn; E F Rittinghaus; R D Hesch
Journal:  Klin Wochenschr       Date:  1989-05-15

Review 5.  Bisphosphonates in osteoporosis?

Authors:  O L Bijvoet; R Valkema; C W Löwik; S E Papapoulos
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 6.  Bisphosphonates and osteoporosis.

Authors:  O H Sørensen; T Storm; G Thamsborg; H A Sørensen; G Kollerup; T Steiniche; F Melsen; H K Genant
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

7.  Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.

Authors:  J F Aloia; A Vaswani; P J Meunier; C M Edouard; M E Arlot; J K Yeh; S H Cohn
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

Review 8.  New bisphosphonates in osteoporosis.

Authors:  H Fleisch
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 9.  The role of bisphosphonates in the prevention and treatment of osteoporosis.

Authors:  J Y Reginster
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

10.  A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.

Authors:  C Hasling; P Charles; F T Jensen; L Mosekilde
Journal:  Osteoporos Int       Date:  1994-07       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.